Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020

Published: November 2015
No. of Pages: 287
   

The molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 million by 2020.

In this report, the molecular diagnostics market is broadly segmented on the basis of technologies, applications, products & services, and end users. On the basis of technology, the market is segmented into PCR, INAAT, microarrays, hybridization, DNA sequencing and next-generation sequencing (NGS), and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate.

The molecular diagnostics market, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and others (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2015, followed by the blood screening and oncology segments.

On the basis of products and services, the molecular diagnostics market is segmented into instruments, reagents, and services & software. The reagents segment is expected to account for the largest share and highest CAGR of the molecular diagnostics market in 2015.

Based on end users, the market is segmented into hospital & academic laboratories, reference laboratories, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). As most diagnostic tests are carried out in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories, owing to which the reference laboratories segment is expected to grow at the highest rate during the forecast period.

The major factors driving this market are high prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the molecular diagnostics market.

Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc.(U.S.), bioMérieux SA (France), and Cepheid Inc. (U.S.).

Scope of the Report

This market study majorly covers the products and services, applications, technologies, and end users for arriving at the overall molecular diagnostics market size in the period from 2015 to 2020.

Market Segmentation

Molecular Diagnostics Market, by Products and Services

  • Instruments
  • Reagents
  • Services & Software             

Molecular Diagnostics Market, by Technology

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)]
  • DNA Sequencing and Next-generation Sequencing
  • Microarrays
  • Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis)

Molecular Diagnostics Market, by Application

  • Infectious Diseases
  • Oncology
  • Genetics
  • Blood Screening
  • Microbiology
  • Others (Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting)

Molecular Diagnostics Market, by End User

  • Reference Laboratories
  • Hospital Laboratories
  • Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point-of-care Settings, and Self-testing)

Molecular Diagnostics Market, by Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)

Asia

  • Japan
  • India
  • China
  • Rest of Asia (RoA)

Rest of the World (RoW)

  • Latin America
  • Brazil
  • Mexico

Rest of Latin America (RoLA)

Pacific Countries

Middle East & Africa

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Molecular Diagnostics Market
4.2 Market,Infectious Diseases
4.3 Market, By Technology and Application
4.4 Market, By End User
4.5 Market, By Products and Services

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence Rate of Infectious Diseases and Various Types of Cancer
5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
5.2.1.3 Development of Biomarker Identification and Advancements in Molecular Techniques
5.2.1.4 Growth in Proteomics and Genomics Research
5.2.1.5 Reforms in the Reimbursement System in the U.S.
5.2.2 Restraints
5.2.2.1 Molecular Diagnostic Tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training
5.2.2.2 Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests
5.2.3 Opportunities
5.2.3.1 Advances in Genomics
5.2.3.2 Significant Growth Prospects in Developing Countries
5.2.4 Challenge
5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies

6 Molecular Diagnostics Market, By Application
6.1 Introduction
6.2 Infectious Diseases
6.2.1 Hepatitis B
6.2.2 Hepatitis C
6.2.3 Human Immunodeficiency Virus (HIV)
6.2.4 Tuberculosis (TB)
6.2.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.6 Human Papillomavirus (HPV)
6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.8 Others
6.3 Oncology
6.3.1 Prostate Cancer
6.3.2 Breast Cancer
6.4 Colorectal Cancer
6.5 Others
6.6 Genetic Tests
6.7 Blood Screening
6.8 Microbiology
6.9 Others

7 Molecular Diagnostics Market, By Technology
7.1 Introduction
7.2 Polymerase Chain Reaction (PCR)
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4 Microarrays
7.5 Hybridization (In-Situ Hybridization & Fish)
7.6 DNA Sequencing and Next-Generation Sequencing
7.7 Other Technologies

8 Molecular Diagnostics Market, By Products and Services
8.1 Introduction
8.2 Reagents
8.3 Instruments
8.4 Software & Services

9 Molecular Diagnostics Market, By End User
9.1 Introduction
9.2 Hospital/Academic Laboratories
9.3 Reference Laboratories
9.4 Other End Users

10 Molecular Diagnostic Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 U.K.
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 Japan
10.4.2 India
10.4.3 China
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Mexico
10.5.1.2 Brazil
10.5.1.3 Rest of Latin America (RoLA)
10.5.2 Pacific Countries
10.5.3 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Molecular Diagnostics Market Competitor Share Analysis, By Application
11.3.1 Market Share Analysis for Infectious Disease Diagnostics Applications
11.3.2 Market Share Analysis for Blood Screening Applications
11.3.3 Market Share Analysis for Microbiology Applications
11.3.4 Market Share Analysis for Oncology Applications
11.3.5 Market Share Analysis for Genetic Testing Applications
11.4 Molecular Diagnostics Market Share Analysis, By Technology
11.4.1 Polymerase Chain Reaction (PCR)
11.4.2 DNA Sequencing and Ngs
11.4.3 Microarray
11.4.4 Hybridization (In Situ and Fluorescence)
11.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.5 Product Approvals
11.6 Agreements, Collaborations, and Partnerships
11.7 New Product Launches
11.8 Acquisitions
11.9 Other Developments

12 Company Profiles
12.1 Introduction
12.2 Abbott Laboratories
12.2.1 Business Overview
12.2.2 Abbott Laboratories: Company Snapshot
12.2.3 Products Offered
12.2.4 Recent Developments
12.2.5 MnM View
12.3 Qiagen N.V.
12.3.1 Business Overview
12.3.2 Qiagen N.V.: Company Snapshot
12.3.3 Products & Services Offered
12.3.4 Recent Developments
12.3.5 MnM View
12.4 Roche Diagnostics
12.4.1 Business Overview
12.4.2 Roche Diagnostics: Company Snapshot
12.4.3 Products Offered
12.4.4 Recent Developments
12.4.5 MnM View
12.5 Hologic, Inc.
12.5.1 Business Overview
12.5.2 Hologic, Inc.: Company Snapshot
12.5.3 Products Offered
12.5.4 Recent Developments
12.5.5 MnM View
12.6 Grifols
12.6.1 Business Overview
12.6.2 Grifols: Company Snapshot
12.6.3 Products Offered
12.6.4 Recent Developments
12.6.5 MnM View
12.7 Siemens Healthcare
12.7.1 Business Overview
12.7.2 Siemens Healthcare: Company Snapshot
12.7.3 Products Offered
12.7.4 Recent Developments
12.8 Becton, Dickinson and Company
12.8.1 Business Overview
12.8.2 Becton, Dickinson and Company: Company Snapshot
12.8.3 Products & Services Offered
12.8.4 Recent Developments
12.9 Beckman Coulter Inc. (Wholly Owned Subsidiary of Danaher Corporation)
12.9.1 Business Overview
12.9.2 Danaher Corporation: Company Snapshot
12.9.3 Products & Services Offered
12.9.4 Recent Developments
12.10 Biomérieux SA
12.10.1 Business Overview
12.10.2 Biomérieux: Company Snapshot
12.10.3 Products Offered
12.10.4 Recent Developments
12.11 Cepheid Inc.
12.11.1 Business Overview
12.11.2 Cepheid Inc.: Company Snapshot
12.11.3 Products Offered
12.11.4 Recent Developments

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.3.1 Abbott Laboratories
13.3.2 Qiagen N.V.
13.3.3 Roche Diagnostics
13.3.4 Hologic Inc.
13.3.5 Hologic Inc.
13.3.6 Siemens Healthcare
13.3.7 Becton, Dickinson and Company
13.3.8 Becton, Dickinson and Company
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables

Table 1 High Prevalence of Infectious Diseases & Cancer and Growth in Genomics Research to Drive the Molecular Diagnostics Market
Table 2 Requirement of Highly Skilled Labor and Complex Regulatory Framework Restraining Market Growth
Table 3 Developing Countries Provide Significant  Growth Opportunities for the Molecular Diagnostic Market
Table 4 Dearth of Trained Professionals is Limiting the Appropriate Use of New Molecular Diagnostic Technologies
Table 5 Molecular Diagnostic Market Size, By Application, 2015–2020 (USD Million)
Table 6 Application
Table 7 Infectious Disease Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 8 North America: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 9 Country
Table 10 Europe: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 11 Country/Region
Table 12 Asia: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 13 RoW: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 14 Country/Region
Table 15 Latin America: Infectious Disease Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 16 Country/Region
Table 17 Infectious Diseases Diagnostics Market Size, By Therapeutic Area, 2015–2020 (USD Million)
Table 18 Therapeutic Area
Table 19 Hepatitis B Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 20 Hepatitis B Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 21 Hepatitis C Market Size, By Region, 2015–2020 (USD Million)
Table 22 Hepatitis C Market Size, By Region, 2015–2020 (Million Assays)
Table 23 HIV Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 24 Hepatitis C Market Size, By Region, 2015–2020 (Million Assays)
Table 25 TB Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 26 TB Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 27 CT/NG Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 28 CT/NG Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 29 HPV Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 30 HPV Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 31 MRSA Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 32 MRSA Diagnostics Market Size, By Region, 2015–2020 (Million Assays)
Table 33 Other Infectious Disease Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 34 Oncology Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 35 North America: Oncology Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 36 Europe: Oncology Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 37 Asia: Oncology Diagnostics Market Size, By Country, 2015–2020 (USD Million)
Table 38 RoW: Oncology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 39 Latin America: Oncology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 40 Oncology Diagnostics Market Size, By Type, 2015–2020 (USD Million)
Table 41 Oncology Molecular Diagnostics Market Size, By Biomarker, 2015–2020 (Million Assays)
Table 42 Prostate Cancer Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 43 Breast Cancer Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 44 Colorectal Cancer Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 45 Other Cancer Diagnostics Market Size, By Region, 2015–2020 (USD Million)
Table 46 Genetic Tests Market Size, By Region, 2015–2020 (USD Million)
Table 47 North America: Genetics Tests Market Size, By Country, 2015–2020 (USD Million)
Table 48 Europe: Genetic Tests Market Size, By Country, 2015–2020 (USD Million)
Table 49 Asia: Genetic Tests Market Size, By Country, 2015–2020 (USD Million)
Table 50 RoW: Genetic Tests Market Size, By Country, 2015–2020 (USD Million)
Table 51 Latin America: Genetic Tests Market Size, By Country, 2015–2020 (USD Million)
Table 52 Blood Screening Market Size, By Region, 2015–2020 (USD Million)
Table 53 North America: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 54 Europe: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 55 Asia: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 56 RoW: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 57 Latin America: Blood Screening Market Size, By Country, 2015–2020 (USD Million)
Table 58 Microbiology Molecular Diagnostic Market Size, By Region, 2015–2020 (USD Million)
Table 59 North America: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 60 Europe: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 61 Asia: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 62 RoW: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 63 Latin America: Microbiology Molecular Diagnostic Market Size, By Country, 2015–2020 (USD Million)
Table 64 Other Molecular Diagnostic Applications Market Size, By Region, 2015–2020 (USD Million)
Table 65 North America: Other Molecular Diagnostic Applications Market Size, By Country, 2015–2020 (USD Million)
Table 66 Europe: Other Molecular Diagnostic Applications Market Size, By Country, 2015–2020 (USD Million)
Table 67 Asia: Other Molecular Diagnostic Applications Market Size, By Country, 2015–2020 (USD Million)
Table 68 RoW: Other Molecular Diagnostics Applications Market Size, By Country, 2015–2020 (USD Million)
Table 69 Latin America: Other Molecular Diagnostics Applications Market Size, By Country, 2015–2020 (USD Million)
Table 70 Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 71 Molecular Diagnostic Market Size for PCR, By Region, 2013–2020 (USD Million)
Table 72 North America: Molecular Diagnostic Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 73 Europe: Molecular Diagnostic Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 74 Asia: Molecular Diagnostic Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 75 RoW: Molecular Diagnostic Market Size for PCR, By Region, 2013–2020 (USD Million)
Table 76 Latin America: Molecular Diagnostic Market Size for PCR, By Country, 2013–2020 (USD Million)
Table 77 Molecular Diagnostic Market Size for INAAT, By Region, 2013–2020 (USD Million)
Table 78 North America: Molecular Diagnostic Market Size for INAAT, By Country, 2013–2020 (USD Million)
Table 79 Europe: Molecular Diagnostic Market Size for INAAT, By Country, 2013–2020 (USD Million)
Table 80 Asia: Molecular Diagnostic Market Size for INAAT, By Country, 2013–2020 (USD Million)
Table 81 RoW: Molecular Diagnostic Market Size for INAAT, By Region, 2013–2020 (USD Million)
Table 82 Latin America: Molecular Diagnostics Market Size for INAAT, By Country, 2013–2020 (USD Million)
Table 83 Molecular Diagnostics Market Size for Microarrays, By Region, 2013–2020 (USD Million)
Table 84 North America: Molecular Diagnostics Market Size for Microarrays, By Country, 2013–2020 (USD Million)
Table 85 Europe: Molecular Diagnostics Market Size for Microarrays, By Country, 2013–2020 (USD Million)
Table 86 Asia: Molecular Diagnostics Market Size for Microarrays, By Country, 2013–2020 (USD Million)
Table 87 RoW: Molecular Diagnostics Market Size for Microarrays, By Region, 2013–2020 (USD Million)
Table 88 Latin America: Molecular Diagnostics Market Size for Microarrays, By Country, 2013–2020 (USD Million)
Table 89 Molecular Diagnostics Market Size for Hybridization, By Region, 2013–2020 (USD Million)
Table 90 North America: Molecular Diagnostics Market Size for Hybridization, By Country, 2013–2020 (USD Million)
Table 91 Europe: Molecular Diagnostics Market Size for Hybridization, By Country, 2013–2020 (USD Million)
Table 92 Asia: Molecular Diagnostics Market Size for Hybridization, By Country, 2013–2020 (USD Million)
Table 93 RoW: Molecular Diagnostics Market Size for Hybridization, By Region, 2013–2020 (USD Million)
Table 94 Latin America: Molecular Diagnostics Market Size for Hybridization, By Country, 2013–2020 (USD Million)
Table 95 Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Region, 2013–2020 (USD Million)
Table 96 North America: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Country, 2013–2020 (USD Million)
Table 97 Europe: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Country, 2013–2020 (USD Million)
Table 98 Asia: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Country, 2013–2020 (USD Million)
Table 99 RoW: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Region, 2013–2020 (USD Million)
Table 100 Latin America: Molecular Diagnostics Market Size for DNA Sequencing and Ngs, By Country, 2013–2020 (USD Million)
Table 101 Molecular Diagnostics Market Size for Other Technologies, By Region, 2013–2020 (USD Million)
Table 102 North America: Molecular Diagnostics Market Size for Other Technologies, By Country, 2013–2020 (USD Million)
Table 103 Europe: Molecular Diagnostics Market Size for Other Technologies, By Country, 2013–2020 (USD Million)
Table 104 Asia: Molecular Diagnostics Market Size for Other Technologies, By Country, 2013–2020 (USD Million)
Table 105 RoW: Molecular Diagnostics Market Size for Other Technologies, By Region, 2013–2020 (USD Million)
Table 106 Latin America: Molecular Diagnostics Market Size for Other Technologies, By Country, 2013–2020 (USD Million)
Table 107 Molecular Diagnostics Market Size, By Products & Services, 2015–2020 (USD Million)
Table 108 Product/Service
Table 109 Molecular Diagnostic Reagents Market Size, By Region, 2015–2020 (USD Million)
Table 110 Molecular Diagnostic Reagents Market Size, By Technology, 2015–2020 (USD Million)
Table 111 North America: Molecular Diagnostic Reagents Market Size, By Country, 2015–2020 (USD Million)
Table 112 Europe: Molecular Diagnostic Reagents Market Size, By Country, 2015–2020 (USD Million)
Table 113 Asia: Molecular Diagnostic Reagents Market Size, By Country, 2015–2020 (USD Million)
Table 114 RoW: Molecular Diagnostic Reagents Market Size, By Region, 2015–2020 (USD Million)
Table 115 Latin America: Molecular Diagnostic Reagents Market Size, By Country, 2015–2020 (USD Million)
Table 116 Molecular Diagnostic Instruments Market Size, By Region, 2015–2020 (USD Million)
Table 117 Molecular Diagnostic Instruments Market Size, By Technology, 2015–2020 (USD Million)
Table 118 North America: Molecular Diagnostic Instruments Market Size, By Country, 2015–2020 (USD Million)
Table 119 Europe: Molecular Diagnostic Instruments Market Size, By Country, 2015–2020 (USD Million)
Table 120 Asia: Molecular Diagnostic Instruments Market Size, By Country, 2015–2020 (USD Million)
Table 121 RoW: Molecular Diagnostic Instruments Market Size, By Region, 2015–2020 (USD Million)
Table 122 Latin America: Molecular Diagnostic Instruments Market Size, By Country, 2015–2020 (USD Million)
Table 123 Molecular Diagnostic Software & Services Market Size, By Region, 2015–2020 (USD Million)
Table 124 North America: Molecular Diagnostic Software & Services Market Size, By Country, 2015–2020 (USD Million)
Table 125 Europe: Molecular Diagnostic Software & Services Market Size, By Country, 2015–2020 (USD Million)
Table 126 Asia: Molecular Diagnostic Software & Services Market Size, By Country, 2015–2020 (USD Million)
Table 127 RoW: Molecular Diagnostic Software & Services Market Size, By Region, 2015–2020 (USD Million)
Table 128 Latin America: Molecular Diagnostic Software & Services Market Size, By Country, 2015–2020 (USD Million)
Table 129 Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 130 Market Size for Hospital/Academic Laboratories, By Region, 2013–2020 (USD Million)
Table 131 North America: Market Size for Hospital/Academic Laboratories, By Country, 2013–2020 (USD Million)
Table 132 Europe: Market Size for Hospital/Academic Laboratories, By Country, 2013–2020 (USD Million)
Table 133 Asia: Market Size for Hospital/Academic Laboratories, By Country, 2013–2020 (USD Million)
Table 134 RoW: Market Size for Hospital/Academic Laboratories, By Region, 2013–2020 (USD Million)
Table 135 Latin America: Market Size for Hospital/Academic Laboratories, By Country, 2013–2020 (USD Million)
Table 136 Market Size for Reference Laboratories, By Region, 2013–2020 (USD Million)
Table 137 North America: Market Size for Reference Laboratories, By Country, 2013–2020 (USD Million)
Table 138 Europe: Market Size for Reference Laboratories, By Country, 2013–2020 (USD Million)
Table 139 Asia: Market Size for Reference Laboratories, By Country, 2013–2020 (USD Million)
Table 140 RoW: Market Size for Reference Laboratories, By Region, 2013–2020 (USD Million)
Table 141 Latin America: Market Size for Reference Laboratories, By Country, 2013–2020 (USD Million)
Table 142 Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 143 North America: Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 144 Europe: Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 145 Asia: Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 146 RoW: Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 147 Latin America: Market Size for Other End Users Laboratories, By Country, 2013–2020 (USD Million)
Table 148 Market Size, By Region, 2013–2020 (USD Million)
Table 149 North America: Market Size, By Technology, 2013–2020 (USD Million)
Table 150 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 151 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 152 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 153 U.S.: Market Size, By Technology, 2013–2020 (USD Million)
Table 154 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 155 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 156 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 157 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 158 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 159 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 160 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 161 Europe: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 162 Europe: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 163 Europe: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 164 Europe: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 165 U.K.: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 166 U.K.: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 167 U.K.: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 168 U.K.: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 169 Germany: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 170 Germany: Market Size, By Application, 2013–2020 (USD Million)
Table 171 Germany: Market Size, By Product, 2013–2020 (USD Million)
Table 172 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 173 France: Market Size, By Technology, 2013–2020 (USD Million)
Table 174 France: Market Size, By Application, 2013–2020 (USD Million)
Table 175 France: Market Size, By Product, 2013–2020 (USD Million)
Table 176 France: Market Size, By End User, 2013–2020 (USD Million)
Table 177 Italy: Market Size, By Technology, 2013–2020 (USD Million)
Table 178 Italy: Market Size, By Application, 2013–2020 (USD Million)
Table 179 Italy: Market Size, By Product, 2013–2020 (USD Million)
Table 180 Italy: Market Size, By End User, 2013–2020 (USD Million)
Table 181 Spain: Market Size, By Technology, 2013–2020 (USD Million)
Table 182 Spain: Market Size, By Application, 2013–2020 (USD Million)
Table 183 Spain: Market Size, By Product, 2013–2020 (USD Million)
Table 184 Spain: Market Size, By End User, 2013–2020 (USD Million)
Table 185 RoE: Market Size, By Technology, 2013–2020 (USD Million)
Table 186 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 187 RoE: Market Size, By Product, 2013–2020 (USD Million)
Table 188 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 189 Asia: Market Size, By Technology, 2013–2020 (USD Million)
Table 190 Asia: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 191 Asia: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 192 Asia: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 193 Japan: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 194 Japan: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 195 Japan: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 196 Japan: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 197 India: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 198 India: Molecular Diagnostic Market Size, By Application, 2013–2020 (USD Million)
Table 199 India: Molecular Diagnostic Market Size, By Product, 2013–2020 (USD Million)
Table 200 India: Molecular Diagnostic Market Size, By End User, 2013–2020 (USD Million)
Table 201 China: Molecular Diagnostic Market Size, By Technology, 2013–2020 (USD Million)
Table 202 China: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 203 China: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 204 China: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 205 RoA: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 206 RoA: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 207 RoA: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 208 RoA: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 209 RoW: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 210 RoW: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 211 RoW: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 212 RoW: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 213 Latin America: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 214 Latin America: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 215 Latin America: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 216 Latin America: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 217 Mexico: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 218 Mexico: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 219 Mexico: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 220 Mexico: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 221 Brazil: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 222 Brazil: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 223 Brazil: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 224 Brazil: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 225 RoLA: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 226 RoLA: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 227 RoLA: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 228 RoLA: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 229 Pacific Countries: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 230 Pacific Countries: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 231 Pacific Countries: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 232 Pacific Countries: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 233 Middle East & Africa: Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 234 Middle East & Africa: Molecular Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 235 Middle East & Africa: Molecular Diagnostics Market Size, By Product, 2013–2020 (USD Million)
Table 236 Middle East & Africa: Molecular Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 237 Product Approvals, 2012–2015
Table 238 Agreements, Collaborations, and Partnerships, 2012–2015
Table 239 New Product Launches, 2012–2015
Table 240 Acquisitions, 2012–2015
Table 241 Other Developments, 2012–2015

List of Figures

Figure 1 Research Design
Figure 2 Market Size Estimation and Data Triangulation
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Molecular Diagnostics Market Snapshot (2015 vs 2020)
Figure 5 Reagents to Account for the Largest Share of Molecular Diagnostics Market During the Forecast Period.
Figure 6 Hospital & Academic Laboratories to Lead the Market During the Forecast Period
Figure 7 Infectious Diseases Segment Will Continue to Dominate the Molecular Diagnostics Market During the Forecast Period
Figure 8 Microarray Segment Poised to Witness the Highest Growth Rate From 2015 to 2020
Figure 9 Product Approvals is the Dominant Strategy Among Market Players
Figure 10 Rising Prevalence of Infectious Diseases & Cancer to Drive Market Growth
Figure 11 MRSA Will Be the Fastest-Growing Segment During the Forecast Period
Figure 12 Infectious Diseases Segment Dominates the Molecular Diagnostics Market in 2015
Figure 13 Hospital & Academic Laboratories to Dominate the Molecular Diagnostics Market By 2020
Figure 14 Reagents Segment to Grow at the Highest CAGR During the Forecast Period
Figure 15 Molecular Diagnostics Market: Drivers, Restraints, Opportunities, and Threats
Figure 16 Infectious Disease Diagnostics, the Largest Segment of the Market in 2015
Figure 17 MRSA Diagnostics Holds Highest Growth Potential in the Molecular Diagnostics Market for Infectious Diseases in 2015
Figure 18 North America Will Continue to Lead in Oncology Molecular Diagnostics Market in Forecast Period
Figure 19 EGFR Assay Segment (By Volume) Will Grow at the Highest Pace During the Forecast Period
Figure 20 North America Will Continue to Dominate Genetics Tests Market During the Forecast Period
Figure 21 Asia is the Fastest-Growing Market for Other Applications
Figure 22 PCR to Dominate the Molecular Diagnostic Technologies Market During the Forecast Period
Figure 23 North America to Dominate the PCR Technology Market During the Forecast Period
Figure 24 Asia to Grow at Highest Rate  for the INAAT Technology Market During the Forecast Period
Figure 25 North America to Dominate the Microarrays Market During the Forecast Period
Figure 26 North America to Dominate the DNA Sequencing and Next-Generation Sequencing Market During the Forecast Period
Figure 27 North America to Dominate the Other Technologies Market During the Forecast Period
Figure 28 Reagents to Form the Largest Segment of the Molecular Diagnostics Market in 2015
Figure 29 Molecular Diagnostic Reagents Market in Asia to Grow at Highest Rate in 2015
Figure 30 North America to Command the Largest Share of the Molecular Diagnostic Instruments Market in 2015
Figure 31 Molecular Diagnostics Software & Services Market in Asia to Grow at the Highest Rate
Figure 32 Hospital/Academic Laboratories, the Major End Users of the Molecular Diagnostics Market
Figure 33 North America to Continue to Dominate the Hospital/Academic Laboratories Market During the Forecast Period
Figure 34 Asia: Highest Growth Potential in the Reference Laboratories End-User Market Segment
Figure 35 Germany is the Largest and Fastest-Growing Market for Reference Laboratories
Figure 36 North America is Expected to Be the Largest Regional Segment in the Molecular Diagnostics Market for Other End Users
Figure 37 Asia-Pacific Will Be the Fastest-Growing Region in the Molecular Diagnostics Market
Figure 38 Asian Market for Molecular Diagnostics Products Shows Significant Growth Opportunities
Figure 39  North America Will Continue to Lead the Global Molecular Diagnostics Market in the Forecast Period
Figure 40 North America Molecular Diagnostics Market Snapshot
Figure 41 PCR Technology Segment Will Continue to Lead the North American Market
Figure 42 Microarray Technology Segment is Growing at the Fastest Rate During the Forecast Period
Figure 43 Reagent Segment Will Continue to Dominate Molecular Diagnostics Market in Asia
Figure 44 Hospital/Academic Laboratories Dominate Molecular Diagnostics End-User Market in Japan
Figure 45 Latin America Will Continue to Lead the Molecular Diagnostics Market in RoW
Figure 46 Infectious Disease Will Be the Largest Application Segment of the Molecular Diagnostics Market in RoW
Figure 47 Brazil to Command Largest Share of Latin American Molecular Diagnostics Market in 2015
Figure 48 Product Innovation and Agreements, Collaborations, and Partnerships Were Key Strategies Adopted in the Last Three Years
Figure 49 Global Molecular Diagnostics Market Share, By Key Player, 2014
Figure 50 Global Infectious Disease Diagnostics Market Share, By Key Player, 2014
Figure 51 Global Blood Screening Market Share, By Key Player, 2014
Figure 52 Global Microbiology Market Share, By Key Player, 2014
Figure 53 Global Oncology MDX Diagnostics Market Share, By Key Player, 2014
Figure 54 Global Genetic Testing MDX Diagnostics Market Share, By Key Player, 2014
Figure 55 Global Molecular Diagnostics Market for PCR, Market Share Analysis, By Key Player, 2014 (%)
Figure 56 Global Molecular Diagnostics Market for DNA Sequencing and Ngs, Market Share Analysis, By Key Player, 2014 (%)
Figure 57 Global Molecular Diagnostics Market for Microarray, Market Share Analysis, By Key Player, 2014 (%)
Figure 58 Global Molecular Diagnostics Market for Hybridization, Market Share Analysis, By Key Player, 2014 (%)
Figure 59 Global Molecular Diagnostics Market for INAAT, Market Share Analysis, By Key Player, 2014 (%)
Figure 60 Battle for Market Share: Product Approvals and Agreements, Collaborations, and Partnerships Were Key Strategies
Figure 61 Geographic Revenue Mix of the Top Five Market Players

Published By: MarketsandMarkets
Product Code: MarketsandMarkets1922


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: